XML 38 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A & B Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income
Beginning balance at Jan. 31, 2018 $ 906,238 $ 1 $ 515,272 $ 389,365 $ 1,600
Beginning balance (in shares) at Jan. 31, 2018   142,069,396      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options 14,370   14,370    
Issuance of common stock upon exercise of stock options (in shares)   1,412,949      
Issuance of common stock upon vesting of restricted stock units (in shares)   662,143      
Stock-based compensation expense 36,891   36,891    
Other comprehensive income (1,719)       (1,719)
Net income 94,596     94,596  
Ending balance at Jul. 31, 2018 1,050,376 $ 1 566,533 483,961 (119)
Ending balance (in shares) at Jul. 31, 2018   144,144,488      
Beginning balance at Apr. 30, 2018 974,437 $ 1 539,665 433,675 1,096
Beginning balance (in shares) at Apr. 30, 2018   143,176,585      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options 7,041   7,041    
Issuance of common stock upon exercise of stock options (in shares)   624,571      
Issuance of common stock upon vesting of restricted stock units (in shares)   343,332      
Stock-based compensation expense 19,827   19,827    
Other comprehensive income (1,215)       (1,215)
Net income 50,286     50,286  
Ending balance at Jul. 31, 2018 1,050,376 $ 1 566,533 483,961 (119)
Ending balance (in shares) at Jul. 31, 2018   144,144,488      
Beginning balance at Jan. 31, 2019 1,237,749 $ 1 617,623 619,197 928
Beginning balance (in shares) at Jan. 31, 2019   146,190,079      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options $ 6,915   6,915    
Issuance of common stock upon exercise of stock options (in shares) 1,014,592 1,014,592      
Issuance of common stock upon vesting of restricted stock units (in shares)   643,963      
Stock-based compensation expense $ 49,340   49,340    
Other comprehensive income (1,021)       (1,021)
Net income 152,691     152,691  
Ending balance at Jul. 31, 2019 1,445,017 $ 1 673,878 771,231 (93)
Ending balance (in shares) at Jul. 31, 2019   147,848,634      
Beginning balance at Apr. 30, 2019 1,335,103 $ 1 641,925 691,989 1,188
Beginning balance (in shares) at Apr. 30, 2019   147,030,464      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options 3,476   3,476    
Issuance of common stock upon exercise of stock options (in shares)   488,538      
Issuance of common stock upon vesting of restricted stock units (in shares)   329,632      
Stock-based compensation expense 28,477   28,477    
Other comprehensive income (1,281)       (1,281)
Net income 79,242     79,242  
Ending balance at Jul. 31, 2019 1,445,017 $ 1 $ 673,878 771,231 $ (93)
Ending balance (in shares) at Jul. 31, 2019   147,848,634      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cumulative effect adjustment for Topic 842 adoption [1] $ (657)     $ (657)  
[1]
We adopted ASU 2016-02, “Leases” (Topic 842) using the modified retrospective method as of February 1, 2019 and elected the transition option that allows us not to restate the comparative periods in our financial statements in the year of adoption.